Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is looking for a Process Development Scientist to join our team in our Redwood City office. This person will be working with teams across Analytical Development, Process Development, Quality, and Regulatory Affairs. This role is responsible for designing and executing experiments to support the development of gene therapy products. The Process Development Scientist I will contribute to analytical method development, product characterization, and process optimization. This individual will analyze and interpret complex scientific data, troubleshoot technical challenges, and collaborate cross-functionally to ensure robust and scalable solutions. The role also includes authoring technical reports and supporting regulatory submissions, while maintaining compliance with industry standards and internal quality systems.
Contract duration: 12 months
Note to Recruiters and Agencies:
All recruiter and agency inquiries must go through Adverum’s internal Talent Acquisition team. Unsolicited resumes sent to Adverum will be considered Adverum's property. Adverum’s Talent Acquisition team must expressly engage agencies for any requisition. Direct contact with hiring managers by agencies will not be tolerated and may affect your ability to work with Adverum in the future.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
Experienced security leader sought to define technical strategy, lead research & engineering projects, expand business opportunities, and represent Trail of Bits in publications and conferences.
Senior leader wanted to drive process development, tech transfer, and lifecycle optimization for autologous CAR-T cell therapies at a clinical-stage biopharma advancing toward commercialization.
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is advancing the clinical development of its novel gene therapy candidate, ADVM-022, as a on...
1 jobs